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About 20 years ago I considered where to submit my Wrst
neuropathology paper, a case report, and concluded that
Acta Neuropathologica “is” the appropriate journal. I there-
fore should be red-faced when admitting that it was only a
few years ago (I was already an Editor of this journal) when
I realized that “Acta” is not singular, but it represents the
plural form of the Latin word actum, meaning Wle. Acta
Neuropathologica stands for something like “Roman Files
of Neuropathology”. In my defence, I could only say that
the Latin word acta does indeed exist and means beach, so
that at a time when searching PubMed and submitting
papers can be done online and through wireless on the
beach, the singular form would be up-to-date. On the other
hand, I suggest that the founding editors of this journal
could have intended the plural meaning and this is reXected
in the title of my editorial.
The Acta Neuropathologica always published case
reports. In fact, the very Wrst issue of the journal, which
appeared in 1961, included three case reports, one of them
on Marchiafava–Bignami syndrome written by Kurt Jellin-
ger, the later managing editor of this journal for almost
30 years. In my own inaugural case report mentioned
above, my teacher Jürgen PeiVer and I, hypothesized that
the pleomorphic xanthoastrocytoma is not a glial tumor and
we argued that the two eminent neuropathologists John
Kepes and Lucien Rubinstein, who described this tumor
and gave the name for it, must be wrong. In retrospect, I am
somewhat surprised that Kurt Jellinger Wnally accepted our
manuscript although the reviews were quite critical. For the
neuropathology community as well as the authors, a study
on more cases of PXA might have been more useful than a
single case report with far-reaching conclusions. For me,
the positive consequence of this paper has been a friendship
with John Kepes who magnanimously took care of the
apparently misled youngster.
However, making friends is not a usual reason for writ-
ing up case reports. Why are they written and published
then? Case reports can convey new pathological, pathoge-
netical or clinico-pathological information which are not
yet on the record, or they can provide an overview of the
literature of a rare disease entity based on a single case.
Furthermore, case reports may be educational not only for
the reader, but also for the writing author because beginners
in the Weld of scientiWc writing can acquire knowledge
about how, why, and where to publish. In contrast to exper-
imental studies, subjects of which are usually matching the
primary interests of only a small minority of readers, case
reports are of principle interest to all practicing neuropa-
thologists, as any variant of any disease may be encoun-
tered by any neuropathologist at any time. It is my feeling
that the case reports are on an average more frequently read
than papers on experimental studies and that many neuro-
pathologists love them as readers and authors alike.
What are the types of case reports published in the Acta
during the past few years? In general, we prefer case reports
in which new pathological evidence obtained in a single
case helps to understand a particular disease better. Of
course, papers should be well written and excellently illus-
trated (remember that color Wgures are published free of
charge). Case reports should convey a clear message rather
than describe an enigmatic case with several possible diag-
nostic considerations. It is not suYcient for the educational
aspect alone to be Wne. We do not publish “we report the
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27th case of XYZ and review the literature” variants of case
report and also we do not endorse submitting “gut feeling
case papers” (“I have never seen this. Must be rare. We
should write it up as a case report”). Not entirely needless
to say that the case reports submitted to this journal should
deal with neuropathology, at least in part.
Even though case reports are often interesting and well
perceived, the prevailing view is that they are not well cited
and therefore tend to decrease the journal’s impact factor
(IF). Given the still ongoing hysteria surrounding the IF,
editors have no choice other than trying to increase this
magic Wgure, not primarily because of higher prestige but in
the hope of attracting “best” papers. Funding agencies and
evaluation committees exert increased pressure on scien-
tists to publish in journals with the highest IF. Conse-
quently, the number of submissions increases with the IF
and editors can select from a higher number of papers, ide-
ally leading to increased quality of the accepted papers and
usually it further increases the IF. Editors therefore tend to
develop implicit or explicit strategies for increasing their
journal’s IF (and to simultaneously announce that it is the
quality that counts, not the IF). One option could be the
sheer elimination of case reports. In fact, the more scientiWc
the attitude of a journal, the less probable it includes a case
report category (at least under this designation). Likewise,
the number of case presentations has decreased at meetings
of some national neuropathology societies, presumably
because of their “non-scientiWc” nature. Milder approach is
to “hide” them under the letter or correspondence category.
The reason is that the yearly IF calculation performed by
the Institute for ScientiWc Information (ISI) counts letters in
the numerator (citations) but not in the denominator (pub-
lished articles), i.e. although letters are usually very rarely
cited, they can potentially increase the IF, but they will
never decrease it. However, ISI’s policy concerning case
reports is not really transparent. On the one hand, ISI com-
municates that it carefully checks each case presentation in
order to prevent mere renaming case reports as letters. On
the other hand, some journals have managed not to include
even their full case reports with abstracts in the denomina-
tor. It somehow appears that not only the IF itself but also
its calculation is surrounded by magic or aVected by poli-
tics.
Is it true that case reports are infrequently cited? The lat-
est IF (2006) refers to citations in 2006 of articles published
in 2004 and 2005. I screened seven journals, primarily deal-
ing with neuropathology for single case studies published
in 2004/2005. I deWned them as papers either appearing in
the category of case report or dealing with a single case
irrespective of the category (original paper, correspon-
dence, neuropathology education, etc.). I identiWed 189
papers (Table 1). Most of them appeared in “Neuropathol-
ogy” and “Acta Neuropathologica” (49 papers each), fol-
lowed by “Clinical Neuropathology” (40 papers). On
average, the mean “Case IF” (citations in 2006 divided by
publications in 2004 and 2005, each of them restricted to
case presentations) was 0.74. For all journals, the Case IF
was <50% of the “oYcial” IF (Table 1). Papers without
abstract were hardly cited with a Case IF of 0.11 as com-
pared to a Case IF of 0.88 for full case reports (with
abstract). Furthermore, 112 of 189 papers (59%) did not
receive a single citation in 2006. Even though it is debat-
able whether the evaluation of case reports by citation sta-
tistics makes much sense, the data reXect that the case
reports indeed are decreasing the IF of neuropathology
journals. On the other hand, occasional case reports have
been remarkably cited often. Table 2 shows Wve papers on
single cases that have received more than ten citations at
present, indicating that the case reports are not necessarily
ignored in the literature. It is hard to Wnd something com-
mon in these Wve case reports but all of them provide
important contributions in areas of very active research and
clinical interest.
What does that mean for Acta Neuropathologica and
their case reports? Not actually too much. In 2007, we
have published on an average one case report per issue, in
Table 1 Number of papers on single cases (published in 2004 and 2005) and their citations (2006) in neuropathology journals
“Case Impact Factors”, calculated only for case presentations in analogy to ISI’s impact factor, are considerably lower than the “oYcial” overall
impact factors
IF 2006 Full case reports  Case letters (no abstract)
Citations  Number  Case IF Citations Number Case IF
J Neuropathol Exp Neurol 4.37 10 5 2.00
Acta Neuropathol 2.69 58 40 1.45 2 9 0.22
Neuropathol Appl Neurobiol 2.68 2 2 1.00 1 6 0.17
Neuropathology 1.26 29 35 0.83 0 14 0.00
Clin Neuropathol 1.03 24 40 0.60
Brain Pathol 5.27 8 19 0.42 1 6 0.17
Folia Neuropathol 0.98 5 13 0.38Acta Neuropathol (2008) 115:269–271  271
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addition to shorter reports occasionally, in the format of
case letters, and we will continue to do that. Even though
the main focus of this journal is on original papers, we
are happy to publish excellent papers on single cases,
which report novel Wndings and help to understand a
disease better. We hope that this policy will make the
“Acta” an even more interesting journal and that some of
our case reports may eventually help to substantially
promote the Weld.
Table 2 Case reports published in 2004/2005 which have received more than ten citations until now (date of analysis, 30 November 2007)
Years of publication are given in parentheses following authors’ names 
Ref. Authors Title Citations
J Neuropathol Exp 
Neurol 63:363–380
Vidal et al. (2004) Intracellular ferritin accumulation in neural and extraneural 
extraneural tissue characterizes a neurodegenerative 




Vendrely et al. (2005) Fulminant inXammatory leukoencephalopathy associated 




Seilhean et al. (2004) Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions 16
Clin Neuropathol 
23:183–93
Mackenzie and Feldman 
(2004)
NeuroWlament inclusion body disease with early onset, frontotemporal 




Leung et al. (2004) A pathogenic peripherin gene mutation in a patient with 
amyotrophic lateral sclerosis
11